Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT04789655 · TERMINATED

Trial details

NCT number: NCT04789655
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid

Start date: 2021-06-16
Primary completion: 2025-04-14
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.